| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Sr. V.p. &CFO, Corp. Dev. | CFO &SVP, Corp. Dev.
2 companies
Henderson Jane is a Chief Financial Officer at Apogee Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $14.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 2,000 | $85.00 | $170,000.00 | -1.1% | - | - | |
| Jan 6, 2026 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 8,000 | $76.14 | $609,145.60 | -1.4% | +7.4% | - | |
| Dec 19, 2025 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 1,500 | $80.00 | $120,000.00 | -0.8% | -12.8% | - | |
| Dec 4, 2025 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 1,500 | $75.00 | $112,500.00 | -0.8% | -4.3% | - | |
| Nov 25, 2025 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 1,500 | $70.00 | $105,000.00 | -0.8% | -1.3% | - | |
| Nov 14, 2025 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 2,000 | $65.00 | $130,000.00 | -1.0% | +5.8% | - | |
| Nov 11, 2025 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 1,000 | $60.00 | $60,000.00 | -0.5% | -1.3% | - | |
| Aug 23, 2024 | APGE Apogee Therapeutics, Inc. | Chief Financial Officer | Sell | 6,000 | $48.26 | $289,560.00 | -2.9% | -11.4% | -20.9% | |
| Mar 23, 2018 | VYGR Voyager Therapeutics, Inc. | Sr. V.p. &CFO, Corp. Dev. | Sale+OE | 31,100 | $20.87 | $649,117.00 | -100% | - | - | |
| Mar 19, 2018 | VYGR Voyager Therapeutics, Inc. | CFO &SVP, Corp. Dev. | Sale+OE | 17,316 | $22.11 | $382,808.40 | -100% | - | - |